OBJECTIVE: To analyze diffusion tensor imaging (DTI) data in the substantia nigra (SN) using a more consistent region of interest (ROI) defined by neuromelanin-sensitive MRI in order to assess Parkinson's disease (PD) related changes in diffusion characteristics in the SN. METHODS: T1 -weighted and DTI data were obtained in a cohort of 37 subjects (17 control subjects and 20 subjects with PD). The subjects in the PD group were clinically diagnosed PD patients with an average Unified Parkinsonian Disease Rating Scale (UPDRS)-III score of 23.2 ± 9.3. DTI data were analyzed using SN ROIs defined by neuromelanin-sensitive MRI and, for comparison, with ROIs defined on T2 -weighted images (b = 0 images). RESULTS: Compared with control subjects, significantly lower fractional anisotropy was observed in PD in the neuromelanin SN ROI but not in the ROI derived from the T2 -weighted image. This decrease was largest in the rostral and lateral portions of the neuromelanin volume, which were found to have more hypointensity in the T2 -weighted image and, presumably, higher iron content in the PD group. In addition, a larger decrease in fractional anisotropy was seen in the SN region of interest on the side contralateral to the side exhibiting more severe symptoms. These results indicate that the use of neuromelanin sensitive MRI to define the ROI in the SN for analyzing DTI data leads to more significant results, enhancing the robustness of DTI study and DTI based biomarkers of PD. Hum Brain Mapp 37:2547-2556, 2016.
OBJECTIVE: To analyze diffusion tensor imaging (DTI) data in the substantia nigra (SN) using a more consistent region of interest (ROI) defined by neuromelanin-sensitive MRI in order to assess Parkinson's disease (PD) related changes in diffusion characteristics in the SN. METHODS: T1 -weighted and DTI data were obtained in a cohort of 37 subjects (17 control subjects and 20 subjects with PD). The subjects in the PD group were clinically diagnosed PDpatients with an average Unified Parkinsonian Disease Rating Scale (UPDRS)-III score of 23.2 ± 9.3. DTI data were analyzed using SN ROIs defined by neuromelanin-sensitive MRI and, for comparison, with ROIs defined on T2 -weighted images (b = 0 images). RESULTS: Compared with control subjects, significantly lower fractional anisotropy was observed in PD in the neuromelanin SN ROI but not in the ROI derived from the T2 -weighted image. This decrease was largest in the rostral and lateral portions of the neuromelanin volume, which were found to have more hypointensity in the T2 -weighted image and, presumably, higher iron content in the PD group. In addition, a larger decrease in fractional anisotropy was seen in the SN region of interest on the side contralateral to the side exhibiting more severe symptoms. These results indicate that the use of neuromelanin sensitive MRI to define the ROI in the SN for analyzing DTI data leads to more significant results, enhancing the robustness of DTI study and DTI based biomarkers of PD. Hum Brain Mapp 37:2547-2556, 2016.
Authors: Ashley K Lotfipour; Samuel Wharton; Stefan T Schwarz; V Gontu; Andreas Schäfer; Andrew M Peters; Richard W Bowtell; Dorothee P Auer; Penny A Gowland; Nin P S Bajaj Journal: J Magn Reson Imaging Date: 2011-10-10 Impact factor: 4.813
Authors: Stephen M Smith; Mark Jenkinson; Mark W Woolrich; Christian F Beckmann; Timothy E J Behrens; Heidi Johansen-Berg; Peter R Bannister; Marilena De Luca; Ivana Drobnjak; David E Flitney; Rami K Niazy; James Saunders; John Vickers; Yongyue Zhang; Nicola De Stefano; J Michael Brady; Paul M Matthews Journal: Neuroimage Date: 2004 Impact factor: 6.556
Authors: Noam I Keren; Saeid Taheri; Elena M Vazey; Paul S Morgan; Ann-Charlotte E Granholm; Gary S Aston-Jones; Mark A Eckert Journal: Neuroimage Date: 2015-03-17 Impact factor: 6.556
Authors: Longchuan Li; Xiaoping Hu; Todd M Preuss; Matthew F Glasser; Frederick W Damen; Yuxuan Qiu; James Rilling Journal: Neuroimage Date: 2013-04-17 Impact factor: 6.556
Authors: E Mark Haacke; Muhammad Ayaz; Asadullah Khan; Elena S Manova; Bharani Krishnamurthy; Lakshman Gollapalli; Carlo Ciulla; I Kim; Floyd Petersen; Wolff Kirsch Journal: J Magn Reson Imaging Date: 2007-08 Impact factor: 4.813
Authors: L-L Chan; H Rumpel; K Yap; E Lee; H-V Loo; G-L Ho; S Fook-Chong; Y Yuen; E-K Tan Journal: J Neurol Neurosurg Psychiatry Date: 2007-07-05 Impact factor: 10.154
Authors: Stefan T Schwarz; Maryam Abaei; Vamsi Gontu; Paul S Morgan; Nin Bajaj; Dorothee P Auer Journal: Neuroimage Clin Date: 2013-10-14 Impact factor: 4.881
Authors: Daniel E Huddleston; Jason Langley; Jan Sedlacik; Kai Boelmans; Stewart A Factor; Xiaoping P Hu Journal: Hum Brain Mapp Date: 2017-02-27 Impact factor: 5.038
Authors: Fabiana C C Hirata; João R Sato; Gilson Vieira; Leandro T Lucato; Claudia C Leite; Edson Bor-Seng-Shu; Bruno F Pastorello; Maria C G Otaduy; Khallil T Chaim; Kenia R Campanholo; Natalia P Novaes; Luciano Magalhães Melo; Márcia R Gonçalves; Felipe Barjud Pereira do Nascimento; Manoel Jacobsen Teixeira; Egberto Reis Barbosa; Edson Amaro; Ellison Fernando Cardoso Journal: Eur Radiol Date: 2016-10-05 Impact factor: 5.315
Authors: Zheng Zhong; Douglas Merkitch; M Muge Karaman; Jiaxuan Zhang; Yi Sui; Jennifer G Goldman; Xiaohong Joe Zhou Journal: Radiology Date: 2019-02-19 Impact factor: 11.105
Authors: Katrina Gwinn; Karen K David; Christine Swanson-Fischer; Roger Albin; Coryse St Hillaire-Clarke; Beth-Anne Sieber; Codrin Lungu; F DuBois Bowman; Roy N Alcalay; Debra Babcock; Ted M Dawson; Richard B Dewey; Tatiana Foroud; Dwight German; Xuemei Huang; Vlad Petyuk; Judith A Potashkin; Rachel Saunders-Pullman; Margaret Sutherland; David R Walt; Andrew B West; Jing Zhang; Alice Chen-Plotkin; Clemens R Scherzer; David E Vaillancourt; Liana S Rosenthal Journal: Biomark Med Date: 2017-06-23 Impact factor: 2.851
Authors: T Guttuso; N Bergsland; J Hagemeier; D G Lichter; O Pasternak; R Zivadinov Journal: AJNR Am J Neuroradiol Date: 2018-02-01 Impact factor: 3.825
Authors: Jason Langley; Naying He; Daniel E Huddleston; Shengdi Chen; Fuhua Yan; Bruce Crosson; Stewart Factor; Xiaoping Hu Journal: Mov Disord Date: 2018-12-30 Impact factor: 10.338